Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
21%
ALSO IN CANC
CANC
50
HOLDINGS
48%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 2.5% | 2.9% | 2.5% |
|
AMGEN INC | 2.4% | 2.4% | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.3% | 5.2% | 2.3% |
|
EXELIXIS INC | 2.2% | 3.4% | 2.2% |
|
GILEAD SCIENCES INC | 2.7% | 1.8% | 1.8% |
XBI Overweight Relative to CANC
|
ALNYLAM PHARMACEUTICALS INC | 3.6% |
|
HALOZYME THERAPEUTICS INC | 2.9% |
|
INCYTE CORP | 2.8% |
|
INSMED INC | 2.7% |
|
UNITED THERAPEUTICS CORP | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
BIOMARIN PHARMACEUTICAL INC | 2.5% |
|
BIOGEN IDEC INC | 2.4% |
|
MODERNA, INC. | 2.3% |
|
NATERA INC | 2.2% |
XBI Underweight Relative to CANC
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
 |
MERUS N.V. | -4.5% |
 |
ASTRAZENECA PLC | -4.3% |
|
NOVARTIS AG | -4.2% |
 |
GENMAB A/S SPONSORED ADR | -3.8% |
|
ELI LILLY & CO | -3.6% |
|
REVOLUTION MEDICINES, INC. | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.1% |
|
BEIGENE LTD. SPONSORED ADR | -3.0% |